The estimated Net Worth of Jill Carroll is at least 119 百万$ dollars as of 1 April 2014. Jill Carroll owns over 103,762 units of Pandion Therapeutics stock worth over 119,475,360$ and over the last 11 years Jill sold PAND stock worth over 0$.
Sign up
Jill Carroll PAND stock SEC Form 4 insiders trading
Jill has made over 1 trades of the Pandion Therapeutics stock since 2014, according to the Form 4 filled with the SEC. Most recently Jill bought 103,762 units of PAND stock worth 1,245,144$ on 1 April 2014.
The largest trade Jill's ever made was buying 103,762 units of Pandion Therapeutics stock on 1 April 2014 worth over 1,245,144$. On average, Jill trades about 51,881 units every 0 days since 2014. As of 1 April 2014 Jill still owns at least 1,989,598 units of Pandion Therapeutics stock.
You can see the complete history of Jill Carroll stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Jill Carroll's mailing address?
Jill's mailing address filed with the SEC is C/O PANDION THERAPEUTICS, INC., 134 COOLIDGE AVENUE, WATERTOWN, MA, 02472.
Insiders trading at Pandion Therapeutics
Over the last 4 years, insiders at Pandion Therapeutics have traded over 0$ worth of Pandion Therapeutics stock and bought 1,743,632 units worth 30,815,954$ . The most active insiders traders include Plc Gsk、Capital Management, L.P.Kol...、Daniel J. Becker. On average, Pandion Therapeutics executives and independent directors trade stock every 11 days with the average trade being worth of 9,518,646$. The most recent stock trade was executed by Daniel J. Becker on 19 November 2020, trading 197,716 units of PAND stock currently worth 2,989,466$.
What does Pandion Therapeutics's logo look like?
Complete history of Jill Carroll stock trades at Applied Genetic Technologies Corp、Pandion Therapeutics
Pandion Therapeutics executives and stock owners
Pandion Therapeutics executives and other stock owners filed with the SEC include:
-
Capital Management, L.P.Kol...,
-
Nancy Stagliano,
Director -
Vikas Goyal,
See Remarks -
Joanne L. Viney,
See Remarks -
Partners Gp Viii, L.L.C.Pol...,
-
Rizzuto Carlo,
Director -
Jill Carroll,
Director -
Katina Dorton,
Director -
Donald Frail,
Director -
Christopher Fuglesang,
Director -
Gregg Beloff,
See Remarks -
Alan L Crane,
Director -
Mitchell Mutz,
Director -
Eric D Larson,
Vice President, Finance -
Daniel J. Becker,
Director -
Rahul Kakkar,
Chief Executive Officer -
Plc Gsk,
Director -
John Sundy,
Chief Medical Officer -
Edward D. Freedman,
Chief Operating Officer